Free Trial

NeuroBo Pharmaceuticals (NRBO) Institutional Ownership

NeuroBo Pharmaceuticals logo
$2.40 0.00 (0.00%)
(As of 11:15 AM ET)

Institutional Ownership Changes (13F Filings) for NeuroBo Pharmaceuticals (NASDAQ:NRBO)

Current
Institutional Ownership
Percentage
1.37%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$3.85M
Number of
Institutional Sellers
(last 12 months)
0
Get NRBO Insider Trade Alerts

Want to know when executives and insiders are buying or selling NeuroBo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

NRBO Institutional Buying and Selling by Quarter

NeuroBo Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/6/2024 Ferguson Wellman Capital Management Inc.15,670$50K0.0%N/A0.191%
8/15/2024 Armistice Capital LLC696,829$3.37M0.0%N/A14.204%
8/15/2024 Affinity Asset Advisors LLC89,222$432K0.0%N/A1.819%
2/14/2022 Murchinson Ltd.205,256$251K0.0%N/A0.772%
11/9/2021BlackRock Inc.44,579$166K0.0%-11.3%0.200%
9/3/2021Parametric Portfolio Associates LLC16,530$55K0.0%N/A0.074%
8/16/2021 State Street Corp15,878$53K0.0%-78.6%0.071%
8/13/2021 Northern Trust Corp24,579$82K0.0%-68.9%0.110%
8/13/2021 Vanguard Group Inc.477,918$1.59M0.0%-30.2%2.145%
8/12/2021 Advisory Services Network LLC8,550$28K0.0%N/A0.038%
8/12/2021Ergoteles LLC30,800$103K0.0%N/A0.138%
8/11/2021 Deutsche Bank AG31,090$104K0.0%+1,016.3%0.140%
8/4/2021 Mount Yale Investment Advisors LLC57,425$191K0.0%N/A0.258%
5/18/2021 California State Teachers Retirement System9,817$43K0.0%+52.1%0.044%
5/17/2021 Goldman Sachs Group Inc.10,056$44K0.0%N/A0.045%
5/13/2021 Bank of New York Mellon Corp19,178$84K0.0%N/A0.087%
5/12/2021 JPMorgan Chase & Co.18,449$81K0.0%+69.4%0.083%
5/7/2021BlackRock Inc.226,013$995K0.0%+2.7%1.019%
2/19/2021 JPMorgan Chase & Co.10,889$57K0.0%+234.8%0.055%
2/11/2021 Northern Trust Corp80,860$425K0.0%-5.4%0.411%
2/9/2021 Wells Fargo & Company MN17,562$92K0.0%+1,213.5%0.089%
2/5/2021BlackRock Inc.219,989$1.15M0.0%+5.0%1.339%
11/10/2020 State Street Corp41,439$233K0.0%+7.3%0.252%
(Data available from 1/1/2016 forward)

NRBO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NRBO shares?

During the previous two years, the following institutional investors and hedge funds held shares of NeuroBo Pharmaceuticals shares: Armistice Capital LLC ($3.37M), and Affinity Asset Advisors LLC ($432K), Ferguson Wellman Capital Management Inc. ($50K).Learn more on NRBO's institutional investors.

What percentage of NeuroBo Pharmaceuticals stock is owned by institutional investors?

1.37% of NeuroBo Pharmaceuticals stock is owned by institutional investors. Learn more on NRBO's institutional investor holdings.

Which institutional investors have been buying NeuroBo Pharmaceuticals stock?

The following institutional investors have purchased NeuroBo Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($696.83K), Affinity Asset Advisors LLC ($89.22K), and Ferguson Wellman Capital Management Inc. ($15.67K).

How much institutional buying is happening at NeuroBo Pharmaceuticals?

Institutional investors have bought a total of 801,721 shares in the last 24 months. This purchase volume represents approximately $3.85M in transactions.



This page (NASDAQ:NRBO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners